SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.139+0.9%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Redman12341/16/2025 8:01:16 AM
4 Recommendations

Recommended By
bobbseytwins2001
dorightbythem
JJINV
mannamal

  Read Replies (2) of 1230
 
From huggenberg ST board. I also as mentioned before expect UK approval with either IRP A or B Route way before late 2025. The Investor Presentation 2025 was written weeks if not a month ago, and obliviously things have changed. Hence the reason for PSS/IBRX sitting on their hands. You don’t want to piss off the FDA.

$IBRX Accelerated market entry will occur while the RESQ-201 process is still ongoing. x.com/testame2be57780/statu... Bullish

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News